Skip to main content
Clinical Trials/IRCT20100513003922N4
IRCT20100513003922N4
Recruiting
Phase 1

Comparing the effectiveness of olive leaf extract and Pregabalin on symptomatic treatment of diabetic neuropathy

Kermanshah University of Medical Sciences0 sites66 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 1
Status
Recruiting
Enrollment
66

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Type I and II diabetic patients who have diabetes for at least one year and have diabetic neuropathy pain
  • History of neuropathic pain for at least three months
  • a pain score (VSA) equal to or greater than 4
  • at least 18 years of age or older
  • HbA1c is equal to or less than 11

Exclusion Criteria

  • Pregnant and lactating women
  • ischemic pain or other pain such as pains associated with amputation or arthritis
  • Electroconvulsive Therapy in the past 30 days
  • using warfarin, antiarrhythmic drugs, sedatives, hypnotices, anticonvulsants, NSAIDs and capsaicin in the past 7 days
  • using antipsychotics, antidepressants, opioids and muscle relaxants during the past 14 days
  • using anti\-neuropathic drug and Unwillingness to stop taking it
  • Dependence on alcohol or other drugs
  • important metabolic diseases, cardiovascular diseases, thyroid disease, major blood diseases, reduced kidney function or liver function, bipolar disease, psychosis
  • history of suicide
  • drug sensitivity

Investigators

Similar Trials